Clinical Trials Logo

Clinical Trial Summary

INTRODUCTION: Granuloma annulare is a non-infectious, granulomatous disease that can affect children and adults. Although there are many studies examining adult patients, there are limited studies examining pediatric granuloma annulare cases. It is aimed to examine the demographic, clinical, and pathological features of pediatric granuloma annulare cases in this study. MATERIALS and METHODS: This study was performed retrospectively in a single-center, tertiary dermatology hospital. Forty-one patients, under the age of 18 who were admitted to the dermatology outpatient clinic between 2008-2021 and diagnosed with granuloma annulare were scanned from the hospital database and patient photograph archive. Demographic characteristics, and clinical and histopathological features were evaluated.


Clinical Trial Description

Granuloma annulare; is a non-infectious, granulomatous skin reaction with potential triggers that can affect the adult and pediatric age group. Diabetes mellitus, hyperlipidemia, and malignancy have been described in association with adult granuloma annulare cases. While there are studies on the clinical, pathological features and associated diseases in patients with adult granuloma annulare, a limited number of studies have been conducted on pediatric granuloma annulare patients. Therefore, clinical and histopathological evaluation of pediatric granuloma annulare cases was planned in our study. This study was performed retrospectively in a single-center tertiary dermatology hospital. Patients under the age of 18 who were admitted to the dermatology outpatient clinic between 2008-2021 and diagnosed with granuloma annulare were scanned from the hospital database and patient photograph archive. Cases with uncertain diagnosis were not included in the study. Cases with dermatological findings recorded in detail and/or diagnosed histopathologically were included in the study. Demographic features, lesion localization, lesion characteristics (size, elementary lesion, color), involvement (localized/generalized), histopathological features, concomitant diseases, differential diagnoses in cases with histopathology, regression time and recommended treatments were recorded. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05472636
Study type Observational
Source Istanbul Training and Research Hospital
Contact
Status Completed
Phase
Start date March 11, 2022
Completion date June 1, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT05580042 - Study to Evaluate the Safety and Tolerability of AC-1101 Topical Gel in Patients With Granuloma Annulare Phase 1
Active, not recruiting NCT05650736 - Janus Kinase Inhibition in Granuloma Annulare Phase 2
Completed NCT03630198 - Pain Outcomes Following Intralesional Corticosteroid Injections Phase 4
Completed NCT00720980 - Granuloma Annulare Treated With Rifampin, Ofloxacin, and Minocycline Combination Therapy
Terminated NCT00476697 - UVA1 Light for Scleroderma and Similar Conditions N/A
Completed NCT00129428 - Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix Phase 1/Phase 2
Completed NCT03910543 - Open-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma Annulare Phase 1